What is the most recent earnings date for SOPH stock?
SOPHIA GENETICS SA (SOPH) last reported earnings on 3/3/2026.
NASDAQ:SOPH • CH1125843347
Past quarterly earnings results for SOPHIA GENETICS SA (SOPH), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.25 | -0.24 | -3.20% | -8.70% | 21.707M | 20.936M | 3.68% | 22.41% |
| Q3 2025 | -0.28 | -0.25 | -13.20% | - | 19.462M | 18.488M | 5.27% | 22.77% |
| Q2 2025 | -0.33 | -0.23 | -40.66% | -43.48% | 18.323M | 17.83M | 2.77% | 15.91% |
| Q1 2025 | -0.26 | -0.25 | -2.99% | -23.81% | 17.779M | 17.264M | 2.98% | 12.68% |
| Q4 2024 | -0.23 | -0.23 | -0.67% | 37.84% | 17.733M | 18.074M | -1.89% | 4.02% |
| Q3 2024 | -0.28 | -0.23 | -19.35% | -33.33% | 15.853M | 16.167M | -1.94% | -2.76% |
| Q2 2024 | -0.23 | -0.29 | 20.18% | 30.30% | 15.808M | 17.748M | -10.93% | 5.01% |
| Q1 2024 | -0.21 | -0.28 | 24.68% | 32.26% | 15.779M | 16.796M | -6.06% | 12.98% |
| Q4 2023 | -0.37 | -0.28 | -34.35% | -68.18% | 17.048M | 17.68M | -3.57% | 27.41% |
| Q3 2023 | -0.21 | -0.33 | 36.32% | 30.00% | 16.303M | 15.759M | 3.45% | 39.94% |
| Q2 2023 | -0.33 | -0.31 | -5.59% | -6.45% | 15.054M | 15.54M | -3.13% | 29.00% |
| Q1 2023 | -0.31 | -0.32 | 3.94% | 8.82% | 13.966M | 14.165M | -1.40% | 28.60% |
| Q4 2022 | -0.22 | -0.37 | 40.39% | 21.43% | 13.38M | 13.169M | 1.60% | 22.30% |
| Q3 2022 | -0.30 | -0.39 | 22.60% | - | 11.65M | 11.679M | -0.25% | 12.45% |
| Q2 2022 | -0.31 | -0.40 | 22.07% | - | 11.67M | 12.189M | -4.26% | 14.64% |
| Q1 2022 | -0.34 | -0.34 | -1.01% | - | 10.86M | 11.067M | -1.87% | 20.94% |
| Q4 2021 | -0.28 | -0.36 | 23.04% | - | 10.94M | 11.424M | -4.24% | 39.54% |
| Q3 2021 | -0.30 | -0.36 | 17.54% | - | 10.36M | 10.098M | 2.59% | 44.49% |
| Q2 2021 | -0.31 | -0.40 | 22.07% | - | 10.18M | 8.772M | 16.05% | 71.96% |
| Q1 2021 | - | - | 8.98M | - | 20.05% | |||
| Q4 2020 | - | - | 7.84M | - | - | |||
| Q3 2020 | - | - | 7.17M | - | - | |||
| Q2 2020 | - | - | 5.92M | - | - | |||
| Q1 2020 | - | - | 7.48M | - | - |
Notes
SOPHIA GENETICS SA (SOPH) last reported earnings on 3/3/2026.
SOPHIA GENETICS SA (SOPH) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, SOPHIA GENETICS SA (SOPH) has beaten EPS estimates in 0 out of 4 releases.